88R10861 CJM-D
 
  By: Collier H.R. No. 257
 
 
 
R E S O L U T I O N
         WHEREAS, March is Triple-Negative Breast Cancer Awareness
  Month, and this occasion provides a fitting opportunity to promote
  better understanding of this health issue; and
         WHEREAS, Breast cancer is one of the most commonly diagnosed
  cancers and the second leading cause of cancer death among women in
  the United States; the American Cancer Society estimates that in
  2023, approximately 298,000 women in the U.S. will be diagnosed,
  and more than 43,000 women will lose their lives to the disease; and
         WHEREAS, One of the many forms of breast cancer,
  triple-negative breast cancer, or TNBC, accounts for about 15 to 20
  percent of all diagnosed invasive breast cancer cases in the
  nation, with over 53,700 new cases identified in 2019; and
         WHEREAS, Due to its aggressive behavior, TNBC grows quickly,
  and it is more likely to have spread by the time of detection and to
  come back after treatment than other types of breast cancer; people
  diagnosed with metastatic TNBC have less than a 30 percent chance of
  surviving longer than five years; and
         WHEREAS, Triple-negative breast cancer cells do not contain
  three key receptors that medicines typically target in other types
  of breast cancers; therefore, there are limited options available
  for treatment; patients with an early diagnosis can often be
  treated with chemotherapy, radiation, and surgery, and recent
  innovations in targeted therapies have fueled the fight against the
  disease; and
         WHEREAS, Triple-negative breast cancer disproportionately
  affects younger women, Black and Hispanic women, women with type 2
  diabetes or excess weight in the abdomen, and those with BRCA1
  mutations; studies have shown that disease-specific mortality
  rates are often higher in patients of lower socioeconomic status,
  and compared to non-Hispanic white women, Black women are 48
  percent less likely to receive guideline-adherent care and around
  twice as likely to die from the disease; and
         WHEREAS, While advances in screening and treatment have
  reduced the overall breast cancer mortality rate over the last few
  decades, the disproportionate impact of TNBC on racial and ethnic
  minority communities calls for a heightened awareness about the
  disease-related disparities in order to tackle inequities in health
  care delivery such as inadequate access to screening, diagnostic
  testing, and care; and
         WHEREAS, TNBC is a serious and life-threatening disease, and
  the observance of Triple-Negative Breast Cancer Awareness Month
  serves as a means of rallying support for increased early detection
  and ensuring quality care for all women; now, therefore, be it
         RESOLVED, That the House of Representatives of the 88th Texas
  Legislature hereby recognize March 2023 as Triple-Negative Breast
  Cancer Awareness Month and urge all Texans to learn more about the
  disease.